€26.48
0.17% today
Xetra, Jun 06, 10:45 am CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock price

€26.43
+2.23 9.21% 1M
+6.93 35.54% 6M
+7.12 36.84% YTD
-2.17 7.57% 1Y
-39.72 60.05% 5Y
-99.87 79.07% 10Y
-2.15 7.52% 20Y
Xetra, Closing price Thu, Jun 05 2025
+1.11 4.38%
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Key metrics

Market capitalization €24.87b
Enterprise Value €58.88b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 10.18
EV/Sales (TTM) EV/Sales 1.26
P/S ratio (TTM) P/S ratio 0.53
P/B ratio (TTM) P/B ratio 0.80
Dividend yield 0.42%
Last dividend (FY24) €0.11
Revenue growth (TTM) Revenue growth -0.92%
Revenue (TTM) Revenue €46.58b
EBIT (operating result TTM) EBIT €-839.00m
Free Cash Flow (TTM) Free Cash Flow €5.78b
Cash position €5.38b
EPS (TTM) EPS €-3.31
P/E forward 17.51
P/S forward 0.54
EV/Sales forward 1.28
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Bayer forecast:

8x Buy
36%
14x Hold
64%

Analyst Opinions

22 Analysts have issued a Bayer forecast:

Buy
36%
Hold
64%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
46,579 46,579
1% 1%
100%
- Direct Costs 21,432 21,432
10% 10%
46%
25,147 25,147
9% 9%
54%
- Selling and Administrative Expenses 15,817 15,817
8% 8%
34%
- Research and Development Expense 6,241 6,241
19% 19%
13%
8,005 8,005
24% 24%
17%
- Depreciation and Amortization 8,844 8,844
10% 10%
19%
EBIT (Operating Income) EBIT -839 -839
215% 215%
-2%
Net Profit -3,253 -3,253
4% 4%
-7%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

AD HOC NEWS
one day ago
Die US-Investmentbank Goldman Sachs hat das Kursziel für die Aktien von Bayer DE000BAY0017 von 29,10 auf 33 Euro angehoben und die Papiere von "Neutral" auf "Buy" hochgestuft.
AD HOC NEWS
one day ago
Nach einer Kaufempfehlung von Goldman Sachs sind die Aktien von Bayer DE000BAY0017 am Donnerstagvormittag fast wieder an ihr Jahreshoch von 26,94 Euro zurückgekehrt.
Neutral
Business Wire
2 days ago
SAN DIEGO & BERLIN, Germany--(BUSINESS WIRE)--Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced it has secured exclusive worldwide rights to develop and commercialize the clinical-stage Werner helicase (WRN) covalent inhibitor VVD-214 (RO7589831), strengthening and complementi...
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 90,587
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today